Evidence map›Paper›PMID 35323407›Full record

ReviewBiosensors2022

Progress of Polyaniline Glucose Sensors for Diabetes Mellitus Management Utilizing Enzymatic and Non-Enzymatic Detection.

Velia Osuna, Alejandro Vega-Rios, Erasto Armando Zaragoza-Contreras, Iván Alziri Estrada-Moreno, Rocio B Dominguez

Open access · goldAbstract readReview
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Velia OsunaCONACYT-CIMAV, SC, Av. Miguel de Cervantes #120, Chihuahua C.P. 31136, Mexico.ORCID 0000-0002-5866-4761
Alejandro Vega-RiosCentro de Investigación en Materiales Avanzados, SC, Av. Miguel de Cervantes #120, Chihuahua C.P. 31136, Mexico.ORCID 0000-0002-9156-4703
Erasto Armando Zaragoza-ContrerasCentro de Investigación en Materiales Avanzados, SC, Av. Miguel de Cervantes #120, Chihuahua C.P. 31136, Mexico.ORCID 0000-0003-3010-556X
Iván Alziri Estrada-MorenoCONACYT-CIMAV, SC, Av. Miguel de Cervantes #120, Chihuahua C.P. 31136, Mexico.ORCID 0000-0003-2067-307X
Rocio B DominguezCONACYT-CIMAV, SC, Av. Miguel de Cervantes #120, Chihuahua C.P. 31136, Mexico.
Centro de Investigación en Materiales Avanzados · MX

Funding

CIMAV S.C. 23006
6 · The paper itself

Abstract

Glucose measurement is a fundamental tool in the daily care of Diabetes Mellitus (DM) patients and healthcare professionals. While there is an established market for glucose sensors, the rising number of DM cases has promoted intensive research to provide accurate systems for glucose monitoring. Polyaniline (PAni) is a conductive polymer with a linear conjugated backbone with sequences of single C-C and double C=C bonds. This unique structure produces attractive features for the design of sensing systems such as conductivity, biocompatibility, environmental stability, tunable electrochemical properties, and antibacterial activity. PAni-based glucose sensors (PBGS) were actively developed in past years, using either enzymatic or non-enzymatic principles. In these devices, PAni played roles as a conductive material for electron transfer, biocompatible matrix for enzymatic immobilization, or sensitive layer for detection. In this review, we covered the development of PBGS from 2015 to the present, and it is not even exhaustive; it provides an overview of advances and achievements for enzymatic and non-enzymatic PBGB PBGS for self-monitoring and continuous blood glucose monitoring. Additionally, the limitations of PBGB PBGS to advance into robust and stable technology and the challenges associated with their implementation are presented and discussed.

Indexed as

Biosensing TechniquesDiabetes MellitusAniline CompoundsBlood GlucoseBlood Glucose Self-MonitoringGlucoseHumansAniline CompoundsBlood GlucoseGlucosepolyanilinediabetes mellitusenzymaticglucose monitoringnon-enzymaticpolyaniline

Identifiers

PMID35323407
PMCPMC8946794
OpenAlexW4213428506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.